본문 바로가기

Anthranilate Reduces Pseudomonas aeruginosa Infection Severity Through an Antibiotic-Independent Anti-Virulence Mechanism

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
ANTIBIOTICS-BASEL15(9) · #898 · 2026
피인용
Web of Science 0Scopus 0
JCR IF
JCR 2024 4.6
ISSN
2079-6382

저자

  1. 이혜연제1저자Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  2. 강민희Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  3. 우문흠Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  4. 김은수Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  5. 이준희교신저자Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea

초록

Background/Objectives: Antibiotic resistance is a growing global health challenge, especially with tricky bacteria like Pseudomonas aeruginosa. Anthranilate, previously identified as a signaling molecule in P. aeruginosa, modulates various pathogenicity-related phenotypes by reducing virulence factor production, inhibiting biofilm formation, and increasing antibiotic susceptibility. Based on these good properties as an anti-virulence agent, this study evaluated the actual therapeutic potential of anthranilate using mouse skin infection and lung infection models. Specifically, the efficacy of anthranilate in a standalone treatment was investigated without reliance on conventional antibiotics. Methods: The therapeutic efficacy of anthranilate was evaluated in murine skin and lung infection models of P. aeruginosa. Anthranilate was administered as a standalone treatment, and its effects on bacterial burden, inflammatory responses, and tissue lesion progression were assessed and compared with those of gentamicin treatment. Results: Anthranilate effectively reduced bacterial suppuration, mitigated inflammatory responses, and suppressed lesion progression in infected skin and lung tissues. Notably, anthranilate alone produced therapeutic effects comparable to those of gentamicin. Conclusions: These findings highlight its potential of standalone treatment as an alternative to traditional antibiotics and offer a novel anti-virulence strategy that minimizes selective pressure for resistance development.

키워드

Pseudomonas aeruginosaanthranilateanti-virulence agentquorum sensingmouse skin infectionmouse pulmonary infectionTARGETING VIRULENCEBACTERIAL BIOFILMSGROWTH-PHASESTRATEGIESRESISTANCEPROSPECTSCOMBAT

식별자

Scopus EID
2-s2.0-105051394963
WoS UID
001890845100001